Natco Pharma was one stock which saw some amount of an incremental positive news in today's trading session where the US patents office has ruled in favour or rather against Teva's reissue application on Copaxone.
Natco Pharma stock price
On April 04, 2014, Natco Pharma closed at Rs 748.95, up Rs 36.10, or 5.06 percent. The 52-week high of the share was Rs 877.00 and the 52-week low was Rs 390.00.
The company's trailing 12-month (TTM) EPS was at Rs 28.47 per share as per the quarter ended December 2013. The stock's price-to-earnings (P/E) ratio was 26.31. The latest book value of the company is Rs 160.81 per share. At current value, the price-to-book value of the company is 4.66.
Anda sedang membaca artikel tentang
Natco Pharma upbeat on Copaxone launch
Dengan url
http://gayafashionshow.blogspot.com/2014/04/natco-pharma-upbeat-on-copaxone-launch.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Natco Pharma upbeat on Copaxone launch
namun jangan lupa untuk meletakkan link
Natco Pharma upbeat on Copaxone launch
sebagai sumbernya
0 komentar:
Posting Komentar